Media Kit

Personal Biography

Ms. Stephanie Hoeppner has worked for over 24 years in the environmental laboratory and environmental consulting field. Currently she holds a BSc, an MBA, is a CFMP (Certified Functional Medicine Practitioner), is a diplomate of four high level nutrition programs (two of which are from Ivy League universities), and is a PhD in Public Health – Epidemiology with an emphasis on environmental determinants of chronic disease. She currently is running a specialty laboratory and clinical practice, focusing on human metabolomics, nutritional markers and persistent organic pollutants, environmental forensics, specialty ecotoxicological assessments and routine environmental samples, located in Calgary, Alberta. This venture marries together the fields of toxicology, environmental medicine and environmental reclamation.

Key Areas of Research

Metabolomics, Xenobiotics, Drug Metabolism, Nutrition, Multiple Sclerosis, Autism Spectrum Disorder, Attention Deficit/Hyperactivity Disorder and children with neurodevelopmental disabilities. Novel, small molecule chemistry.

Getting to Know Stephanie More In-Depth

At Life Science Forensics, I am looking at adding technical tools to medical practitioners by offering several products that are outside the scope of what is available by conventional medical testing laboratories. Why look for vitamin B12 in a patient by doing a blood draw, which only evaluates what is currently within the body, when we are capable of instead looking at the end product metabolites, which tell us whether or not that vitamin is being used, and if there is a dysfunction in that metabolic pathway? Similarly, we know that lead is detrimental health and should there be an elevated level in a person, that person would be treated. Why then do we do nothing when a person is similarly carrying a high body burden of other xenobiotics, encompassing analytes that we know are harmful to humans and are being part of extensive human biomonitoring projects all over the world? To simply look at current OSHA and EPA regulations are not enough. There is a gross difference between acute toxicity (upon which most environmental regulations are based) and long-term chronic toxicity and this gap is affecting our ecosystem as well as humans.

Why are 1 in 6 children being born with neurodevelopmental disabilities? Why are 1 in 68 children being diagnosed with autism? Diabetes, certain childhood cancers, autoimmune diseases, autism and many more – these diseases are increasing in prevalence as time progresses. The diseases that we are dying of today are vastly different than they were just 100 years ago, yet the genome of a population does not change in such a short time. What has changed if not our genes? Our environment. All the members of Life Science have been hand-chosen to have experience in both the clinical medical and environmental reclamation world like myself. This gives us the unique multi-disciplinary skill set required to marry together the fields of environmental management and medicine. While there are other players (having originally been solely clinical medical laboratories) mostly within the United States, who dabble in environmental determinants of disease, mine comes from the unique standpoint of being experts in both fields. This has allowed me to put together far superior analytical skills, ground-breaking research and products that are useful to both conventional and alternative medical practitioners, as well as a host of industrial hygiene and other commercial entities who have interests in environmental health.

One of my passions is testing purported “green” products as part of my lifestyle consulting, because what is real and what is just marketing?  We have currently developed a new method to determine in substances are mutagenic, cause DNA damage or oxidative stress, are endocrine disrupting, or are neurotoxic (in other words, seeing if the formulations of these products actually make you sick or cause cancer). We are working on a line of beauty and cleaning products as a part of our commitment to making people’s lives healthier. Our tagline is, “Created By Moms Who Are Also Scientists” (given that we were founded by women, who are mothers). I am a fierce advocate of philanthropy and science education.

TV Links/Internet Links to Stephanie Speaking

http://calgary.ctvnews.ca/new-evidence-of-pesticides-in-calgary-air-soil-1.2416556

http://www.autismone.org/content/stephanie-hoeppner-bsc-mba-testing-heavy-body-burdens-chemicals-autistic-children

TV Links of LSF in the News

http://calgary.ctvnews.ca/video?clipId=595358

Publications and Presentations

Recent Presentations

Brown, B. A., & Hoeppner, S. (2015). Analysis of PFOA Using DART-MS. In RemTech Remediation Technolgies Symposium. Banff, Alberta.

Birkholz, D., Hoeppner, S., Ralitsch, M. (2016). Challenges in Forensic Analyses of Petroleum. In RemTech Remediation Technologies Symposium. Banff, Alberta.

Birkholz, D., Hoeppner, S., Raltisch, M. (2017). Chemometric Determination of Sources of Hydrocarbons from a Large Contaminated Site. In Canadian Land Reclamation Association Conference. Red Deer, Alberta.

Hoeppner, S. (2015). The Testing of Heavy Body Burdens in Children with Autism. In Autism One Conference. Chigago Illinois.

Hoeppner, S. (2016). Alternative Approaches to Animal Testing for Ecotoxicity Assessments – High Throughput Screening Techniques: Once Put on the Shelf, Now Ready for Practicality. In Society for Environmental Chemistry and Toxicology Conference. Atlanta, Georgia.

Hoeppner, S. (2017) Toxicants and Inherent Individual Metabolism – A Novel Screen for Comorbidity Biomarkers. In 3rd International Conference on Autism. Los Angeles, California.

Hoeppner, S. (2017). Emerging Contaminants of Concern in Alberta Waterways – A James Bondesque View at the Real Situation. In WaterTech Water Technologies Symposium. Banff, Alberta.

Hoeppner, S., & Brown, B. A. (2015). Determining Adverse Health Effects in Air. In Canadian Society for Chemistry Conference. Ottawa, Ontario.

Hoeppner, S., & Brown, B. A. (2014). Determining Adverse Health Effects in Air. In Society of Environmental Toxicology and Chemistry Conference. Vancouver, British Columbia.

Hoeppner, S., & Brown, B. A. (2015). Xeno75: Screening for Environmental Toxicants. In Canadian Society for Chemistry Conference. Ottawa, Ontario.

Hoeppner, S., Birkholz, D. (2016) Liability Ownership: Routine GC Data can Provide Erroneous Data for Source Identification. In WaterTech Water Technologies Symposium. Banff, Alberta.

Upcoming:

Birkholz, D., Goudey, S., Hoeppner, S. (2018). Forensic Ecotoxicology: Toxicity Associated with Halogenated Tolyltriazoles Isolated From Industrial Cooling Towers. In EnviroTech 2018 Symposium, Calgary, Alberta.

Hoeppner, S. (2018). Unique Techniques for Determining Salt Impacts or Other Fracking Contamination Using Multiple Forensic Fingerprinting Programs. . In EnviroTech 2018 Symposium, Calgary, Alberta.

Steph photo